Assessing Iparomlimab and Tuvonralimab in Recurrent or Metastatic MSI-H/dMMR Gastric Cancer

Clinical trial NCT07127822 · RECRUITING

Trial details

NCT number: NCT07127822
Sponsor: Peking University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Gastric / Gastroesophageal Junction Adenocarcinoma MSI-H Cancer

Start date: 2025-12-15
Primary completion: 2027-12-31
Enrollment: 106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.